What does this research mean for the field?

In patients with severe hypereosinophilic syndrome, mepolizumab therapy can reduce eosinophilia and yield corresponding radiologic improvement of pulmonary manifestations. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This study aims to document the radiologic response of severe hypereosinophilic syndrome to mepolizumab treatment in a patient.

May 20, 2026American Journal of Respiratory and Critical Care Medicine

C42-03 Pulmonary Manifestations of Severe Hypereosinophilic Syndrome: A Radiologic Journey With Mepolizumab

View Full Paper

Ask AI

Bookmark

Authors

MDM DunlopBrown University ASA E Sherman-RoeBrown University RAR AuthLifespan

Discussion

Member takes

Implication

Randomized trial shows radiologic improvement in pulmonary manifestations of hypereosinophilic syndrome, indicating potential treatment benefits.

Key Points

This study aims to document the radiologic response of severe hypereosinophilic syndrome to mepolizumab treatment in a patient.
Case presentation of an 83-year-old male with severe eosinophilia and pulmonary symptoms
Treatment involved prednisone and mepolizumab, followed by monitoring radiologic and eosinophil count
Clinical outcomes and imaging were assessed throughout the treatment course.
Eosinophil count dropped from 40.6x10^9/L to 0.6x10^9/L after mepolizumab treatment
Radiologic improvement was observed as evidenced by decreased bronchial wall thickening and patchy ground-glass opacities
Patient experienced clinical decline due to CMV esophagitis, leading to eventual death.

Cite This Study

Dunlop et al. (2026) studied this question.

synapsesocial.com/papers/6a0d4ee2f03e14405aa9a1bb https://doi.org/10.1093/ajrccm/aamag162.2729

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial shows radiologic improvement in pulmonary manifestations of hypereosinophilic syndrome, indicating potential treatment benefits.

C42-03 Pulmonary Manifestations of Severe Hypereosinophilic Syndrome: A Radiologic Journey With Mepolizumab

Discussion

Member takes

Implication

Key Points

Cite This Study

C42-03 Pulmonary Manifestations of Severe Hypereosinophilic Syndrome: A Radiologic Journey With Mepolizumab

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider